The global menopausal hot flashes market size was worth USD 31,926.50 million in 2021 and is estimated to grow to USD 42,297.91 million by 2028, with a compound annual growth rate (CAGR) of approximately 4.80 percent over the forecast period.
The global menopausal hot flashes market size was worth USD 31,926.50 million in 2021 and is estimated to grow to USD 42,297.91 million by 2028, with a compound annual growth rate (CAGR) of approximately 4.80 percent over the forecast period. The report analyzes the menopausal hot flashes market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the menopausal hot flashes market.
Menopause is patent by hot flashes, which are the furthermost common. Hot flashes are thought to result from changes in the hypothalamus, the part of the brain that regulates body temperature; However, the exact reason is still unknown. The rise of postmenopausal symptoms due to the shift to a sedentary lifestyle is expected to drive the market. The increasing incidence of vasomotor and menopausal symptoms such as night sweats and hot flashes among women during the menopausal transition is expected to drive market growth. In addition, problems such as mood swings, difficulty concentrating, and depression are associated with menopause. In addition, increased investment in treating menopausal manifestations is expected to boost the market.
The COVID-19 pandemic has impacted the businesses of menopausal hot flashes. The COVID-19 pandemic spread throughout the world as strict lock-downs are implemented by governments and shut down companies. Thus, the movement of people is restricted during the Covid-19 pandemic; the global menopausal hot flashes market is likely to be impacted considerably during the forecast period.
The increasing prevalence of menopausal hot flashes aids the global market growth
The main driving factors of the global menopausal hot flashes market are the increasing prevalence of menopausal hot flashes, the growing number of new pharmacological approvals for the treatment, and increasing health awareness. Hot flashes are a rapid feeling of heat that mainly affects the chest, neck, and face. Some key variables driving the strong growth of the menopausal hot flashes market are the frequency of fluctuations in high estrogen levels and impaired musculoskeletal health in women. As a result, healthcare companies are stepping up clinical studies of hormone-free products to meet various needs.
The side effects related to menopausal hot flashes may hamper the global market growth
The key restraints for the menopausal hot flashes market are the side effects of menopausal hot flashes, such as vaginal bleeding, hip & vertebral fractures, dementia, urinary incontinence, breast cancer, heart attack, blood clots, stroke, colon cancer rectal. Because of these side effects, patients seek safer treatments such as herbal products and supplements, major restraint that is expected to impede the growth of the global menopausal hot flashes market during the forecast period.
The advancements by market players bring up several growth opportunities
Companies in the global menopausal hot flashes market recommend lifestyle changes for women through online media. Likewise, companies are developing innovative devices tailored to the needs of women. For example, the introduction of Monopod has fueled the growth of the menopause flash market due to its compact mouse-like shape and portability. The advent of smartwatch-type devices that act as personal thermostats for women is also driving the global market.
The global menopausal hot flashes market is segregated based on treatment type, distribution channel, and region.
By treatment type, the market is divided into hormonal treatment, non-hormonal treatment, and alternative treatment. Among these, in 2021, the hormonal treatment segment dominated the market, accounting for a significant percentage of global sales due to the increasing demand for menopausal hot flashes treatment. Also, it will grow with the highest CAGR during the forecast period.
By distribution channel, the market is categorized into retail pharmacies, hospital pharmacies, and online pharmacies. Over the forecast period, the hospital pharmacies segment is expected to develop at the fastest rate due to the increased checkups in hospitals.
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
The growing population of geriatric women helps North America dominates the global market
North America is leading the global menopausal hot flashes market due to the growing population of geriatric women with menopausal symptoms in the United States and Canada. This industry is expected to grow to meet the increasing demand for medical treatments during hot flashes. According to the National Center for Biotechnology Information (NCBI), about 85% of postmenopausal women have experienced symptoms related to menopause (hot flashes). According to the North American Menopause Society, about 75% of North American women experience hot flashes during perimenopause. Nearly a quarter of them are so bothered that they need to see a doctor. Menopause is common among older women, increasing the market's overall growth rate. In addition, technical improvements in the production of new pharmaceuticals, increased spending on healthcare and the presence of a well-established healthcare infrastructure all contribute to the market's growth.
Some of the main competitors dominating the global menopausal hot flashes market include - Pfizer Inc., Novartis AG, Novo Nordisk A/S, Allergan plc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., GlaxoSmithKline plc, TherapeuticsMD Inc.
By Treatment Type
By Distribution Channel
By Region
The main driving factors of the menopausal hot flashes market are the increasing prevalence of menopausal hot flashes, the growing number of new pharmacological approvals for the treatment, and increasing health awareness. Hot flashes are a rapid feeling of heat that mainly affects the chest, neck, and face. Hot flashes are an immediate feeling of warmth that affects the chest, neck, and face. Some key variables driving the strong growth of the menopausal hot flashes market are the frequency of fluctuations in high estrogen levels and impaired musculoskeletal health in women. As a result, healthcare companies are stepping up clinical studies of hormone-free products to meet various needs.
According to a report, the global menopausal hot flashes market was worth 31,926.50 (USD million) in 2021 and is predicted to grow to 42,297.91 (USD Million) by 2028, with a compound annual growth rate (CAGR) of about 4.80 percent.
North America is leading the menopausal hot flashes market due to the growing population of geriatric women with menopausal symptoms in the United States and Canada. This industry is expected to grow to meet the increasing demand for medical treatments during hot flashes. In addition, technical improvements in the production of new pharmaceuticals, increased spending on healthcare and the presence of a well-established healthcare infrastructure all contribute to the market's growth.
Some of the main competitors dominating the global menopausal hot flashes market include Pfizer Inc., Novartis AG, Novo Nordisk A/S, Allergan plc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., GlaxoSmithKline plc, TherapeuticsMD Inc.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed